RankAlpha logo
Back to Rankings

RVTY

RevvityD
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart

Operating peers and competitors

Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.

Loading market evidence...

Research comparisons do not establish forecast usefulness or trading returns.

Compare shared product markets

Membership only; no portfolio weights or estimated losses.

+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
RVTY vs peer average
24/100
RVTY vs. peer average (D vs. B)
Grade spread
A 3 · B 3 · C 2 · D 1 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ARWR is the first available peer comparator.

Higher-beta biotech reference for growth and optionality; business mix is materially different, so comparison is loose.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerARWRArrowhead
RVTY
Revvity
ARWR
Arrowhead
Grade
D
B
Momentum
97
13
Value
60
41
Sentiment
29
89
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs ARWR

RVTY / ARWR
Grade Position
Below peers
RVTY vs. peer average (D vs. B)
24/100
Momentum
97
RVTY
Value
60
RVTY
Sentiment
29
ARWR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RVTY
1
ARWR
ARWR
B
80/100
+2
2
CRL
CRL
C
60/100
+1
3
GILD
GILD
A
100/100
+3
4
MEDP
Medpace Holdings Inc Common
D
40/100
Even
5
EXEL
Exelixis Inc Common
C
60/100
+1
ARWR is the first peer returned for this comparison set.